financetom
Business
financetom
/
Business
/
Gucci-owner Kering posts 10% drop in Q1 sales on sluggish Chinese demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gucci-owner Kering posts 10% drop in Q1 sales on sluggish Chinese demand
Apr 23, 2024 9:31 AM

PARIS (Reuters) -French luxury group Kering reported a 10% drop in first-quarter sales on Tuesday, dragged down by a slowdown at its star label Gucci, which suffered from weakness in Asia while undergoing a design overhaul.

The group said its first half operating profit would be "sharply lower" due to the revenue decline and its ongoing investment in its brands.

Sales for the three months ending in March stood at 4.5 billion euros ($4.82 billion), down 10% on a comparable basis.

Kering had warned on March 19 that sales over the period were likely to drop by around 10%, dashing hopes it had stemmed sales declines at Gucci, the century-old Italian fashion house which accounts for half of group sales and two-thirds of profit.

The warning prompted concern in the luxury sector about prospects for China's rebound - traditionally Gucci's most coveted market - which has been clouded by a property crisis and high youth unemployment.

Sales at Gucci in the first quarter were down 18%, significantly worse than the 4% decline in the prior quarter, the company reported.

Kering reiterated its plans to continue investing in Gucci this year, with margins likely to be dented as a result.

The first designs from new creative director Sabato de Sarno began trickling into stores in mid-February.

Kering has been pushing the brand upmarket, with a focus on classic leather goods, and says that early products from the new Ancora collection, which include glossy Jackie bags and chunky, platform loafers, have been well received.

Kering shares have dropped 18% since March 19, while rivals LVMH and Hermes are down 7.5% and 2.8%, respectively.

(Reporting by Mimosa Spencer; Editing by Emelia Sithole-Matarise)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mongodb Insider Sold Shares Worth $3,466,497, According to a Recent SEC Filing
Mongodb Insider Sold Shares Worth $3,466,497, According to a Recent SEC Filing
Mar 5, 2024
05:15 PM EST, 03/05/2024 (MT Newswires) -- Dwight A Merriman, Director, on March 01, 2024, sold 8,000 shares in Mongodb ( MDB ) for $3,466,497. Following the Form 4 filing with the SEC, Merriman has control over a total of 1,780,680 shares of the company, with 1,160,784 shares held directly and 619,896 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1441816/000144181624000042/xslF345X03/wk-form4_1709676677.xml Price: 411.49, Change:...
Apollo Global Management Insider Sold Shares Worth $22,948,598, According to a Recent SEC Filing
Apollo Global Management Insider Sold Shares Worth $22,948,598, According to a Recent SEC Filing
Mar 5, 2024
05:16 PM EST, 03/05/2024 (MT Newswires) -- Scott Kleinman, Director, and Co-President of Apollo Asset Management, Inc., on March 01, 2024, sold 207,580 shares in Apollo Global Management ( APO ) for $22,948,598. Following the Form 4 filing with the SEC, Kleinman has control over a total of 8,224,178 shares of the company, with 4,692,393 shares held directly and 3,531,785...
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing
Mar 5, 2024
05:15 PM EST, 03/05/2024 (MT Newswires) -- John F Crowley, Director, Executive Chairman, on March 01, 2024, sold 29,181 shares in Amicus Therapeutics ( FOLD ) for $389,543. Following the Form 4 filing with the SEC, Crowley has control over a total of 638,373 shares of the company, with 573,478 shares held directly and 64,895 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1178879/000095017024026265/xslF345X03/ownership.xml...
Bayer notches more wins in Roundup weedkiller cancer trials
Bayer notches more wins in Roundup weedkiller cancer trials
Mar 5, 2024
March 5 (Reuters) - Bayer on Tuesday said it won a trial in a lawsuit brought by a retired postal service worker in Pennsylvania who alleged he developed non-Hodgkins lymphoma from using the company's Roundup weedkiller. In addition to the jury verdict in the Philadelphia Court of Common Pleas, Bayer said a California farmer, who said he contracted the same...
Copyright 2023-2026 - www.financetom.com All Rights Reserved